Rxivist logo

NADH as a cancer medicine

By Michael D Forrest

Posted 13 May 2015
bioRxiv DOI: 10.1101/019307

We propose that NADH will exert a specific kill action against some cancers. NADH is a natural metabolite. We envisage a low side effect profile and that NADH therapy will, additionally, combat the wastage and weakness of cancer patients, which can be the cause of death in some cases. Significantly, NADH can be administered orally and has already cleared clinical trials, all be it for other pathologies.

Download data

  • Downloaded 5,361 times
  • Download rankings, all-time:
    • Site-wide: 589 out of 83,779
    • In cancer biology: 14 out of 2,924
  • Year to date:
    • Site-wide: 5,055 out of 83,779
  • Since beginning of last month:
    • Site-wide: 4,650 out of 83,779

Altmetric data


Downloads over time

Distribution of downloads per paper, site-wide


PanLingua

Sign up for the Rxivist weekly newsletter! (Click here for more details.)


News